Claire,
Thank you for the info. I was really looking for LMTX tests for Parkinson. I am happy they are already in clinical phase I with it. If the Alzheimer clinical trial III is positive, something which I really believe in, then in 4 years LMTX will be sold for Alzheimer. By then, I guess clinical phase II of LMTX in PD will already have given indications whether LMTX is beneficial for PD or not, as well as the optimal dosis. If so, then people with PD will probably get LMTX off label too in 4 years from now.